A detailed history of Vigilant Capital Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 750 shares of MRNA stock, worth $41,040. This represents 0.01% of its overall portfolio holdings.

Number of Shares
750
Previous 750 -0.0%
Holding current value
$41,040
Previous $115,000 20.87%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 07, 2022

SELL
$126.46 - $235.05 $1,011 - $1,880
-8 Reduced 1.06%
750 $129,000
Q2 2021

Jul 09, 2021

BUY
$129.91 - $234.98 $1,039 - $1,879
8 Added 1.07%
758 $178,000
Q2 2020

Jul 10, 2020

BUY
$29.67 - $80.0 $22,252 - $60,000
750 New
750 $48,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Vigilant Capital Management, LLC Portfolio

Follow Vigilant Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.